Lynn M. Bodarky
Corporate Officer/Principal chez ACTINIUM PHARMACEUTICALS, INC.
Profil
Lynn M.
Bodarky is currently the Chief Business Officer at Actinium Pharmaceuticals, Inc. Previously, she was the Vice President of Business Development at Geron Corp.
from 2019 to 2021 and the Vice President of Marketing at Progenics Pharmaceuticals, Inc. from 2004 to 2007.
She also held the position of Senior VP & Global Head of Business Development at HiFiBiO Inc. Ms. Bodarky has an MBA from The Trustees of Columbia University in The City of New York and an undergraduate degree from The Wharton School of the University of Pennsylvania.
Postes actifs de Lynn M. Bodarky
| Sociétés | Poste | Début |
|---|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 03/11/2023 |
Anciens postes connus de Lynn M. Bodarky
| Sociétés | Poste | Fin |
|---|---|---|
| GERON CORPORATION | Corporate Officer/Principal | 01/01/2021 |
| PROGENICS PHARMACEUTICALS, INC. | Sales & Marketing | 01/01/2007 |
HiFiBiO Inc.
 HiFiBiO Inc. Pharmaceuticals: MajorHealth Technology HiFiBiO Inc. develops and manufactures pharmaceutical products. It specializes in antibodies, that mobilize the human immune system to combat cancer, autoimmune disorders, and other unmet medical needs. The company was founded by Liang Schweizer, Fred Dom, Andrew Griffiths, David Weitz, Bradley Bernstein, J?r?me Bibette, and Robert Nicol and is headquartered in Paris, France. | Corporate Officer/Principal | - |
Formation de Lynn M. Bodarky
| The Trustees of Columbia University in The City of New York | Masters Business Admin |
| The Wharton School of the University of Pennsylvania | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| GERON CORPORATION | Health Technology |
| ACTINIUM PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Progenics Pharmaceuticals, Inc.
 Progenics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Progenics Pharmaceuticals, Inc. engages in the development of medicines and other products for targeting and treating cancer. Its pipeline includes therapeutic agents, imaging agents for prostate cancer, and imaging analysis technology. The company was founded by Paul J. Maddon on December 1, 1986 and is headquartered in New York, NY. | Health Technology |
HiFiBiO Inc.
HiFiBiO Inc. Pharmaceuticals: MajorHealth Technology HiFiBiO Inc. develops and manufactures pharmaceutical products. It specializes in antibodies, that mobilize the human immune system to combat cancer, autoimmune disorders, and other unmet medical needs. The company was founded by Liang Schweizer, Fred Dom, Andrew Griffiths, David Weitz, Bradley Bernstein, J?r?me Bibette, and Robert Nicol and is headquartered in Paris, France. | Health Technology |
